RU2018134644A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018134644A3 RU2018134644A3 RU2018134644A RU2018134644A RU2018134644A3 RU 2018134644 A3 RU2018134644 A3 RU 2018134644A3 RU 2018134644 A RU2018134644 A RU 2018134644A RU 2018134644 A RU2018134644 A RU 2018134644A RU 2018134644 A3 RU2018134644 A3 RU 2018134644A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0012—Cell encapsulation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0678—Stem cells; Progenitor cells; Precursor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/195—Heregulin, neu differentiation factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361781005P | 2013-03-14 | 2013-03-14 | |
| US61/781,005 | 2013-03-14 | ||
| US14/106,330 | 2013-12-13 | ||
| US14/106,330 US8859286B2 (en) | 2013-03-14 | 2013-12-13 | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015137400A Division RU2670064C2 (ru) | 2013-03-14 | 2014-03-13 | Дифференцировка in vitro плюрипотентных стволовых клеток в панкреатические эндодермальные клетки (пэк) и эндокринные клетки |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2020132715A Division RU2764465C1 (ru) | 2013-03-14 | 2020-10-05 | Дифференцировка in vitro плюрипотентных стволовых клеток в панкреатические эндодермальные клетки (пэк) и эндокринные клетки |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018134644A RU2018134644A (ru) | 2019-03-21 |
| RU2018134644A3 true RU2018134644A3 (enExample) | 2019-03-21 |
| RU2734657C2 RU2734657C2 (ru) | 2020-10-21 |
Family
ID=51527928
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015137400A RU2670064C2 (ru) | 2013-03-14 | 2014-03-13 | Дифференцировка in vitro плюрипотентных стволовых клеток в панкреатические эндодермальные клетки (пэк) и эндокринные клетки |
| RU2018134644A RU2734657C2 (ru) | 2013-03-14 | 2014-03-13 | Дифференцировка in vitro плюрипотентных стволовых клеток в панкреатические эндодермальные клетки (пэк) и эндокринные клетки |
| RU2020132715A RU2764465C1 (ru) | 2013-03-14 | 2020-10-05 | Дифференцировка in vitro плюрипотентных стволовых клеток в панкреатические эндодермальные клетки (пэк) и эндокринные клетки |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015137400A RU2670064C2 (ru) | 2013-03-14 | 2014-03-13 | Дифференцировка in vitro плюрипотентных стволовых клеток в панкреатические эндодермальные клетки (пэк) и эндокринные клетки |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2020132715A RU2764465C1 (ru) | 2013-03-14 | 2020-10-05 | Дифференцировка in vitro плюрипотентных стволовых клеток в панкреатические эндодермальные клетки (пэк) и эндокринные клетки |
Country Status (12)
| Country | Link |
|---|---|
| US (6) | US8859286B2 (enExample) |
| EP (2) | EP3521418A1 (enExample) |
| JP (7) | JP6219494B2 (enExample) |
| KR (7) | KR102077367B1 (enExample) |
| AU (6) | AU2014243791B2 (enExample) |
| CA (2) | CA2897984C (enExample) |
| DK (1) | DK2970899T3 (enExample) |
| ES (1) | ES2739082T3 (enExample) |
| IL (4) | IL317491A (enExample) |
| RU (3) | RU2670064C2 (enExample) |
| SG (2) | SG11201505866RA (enExample) |
| WO (1) | WO2014160413A1 (enExample) |
Families Citing this family (103)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
| CA3207103A1 (en) | 2007-07-31 | 2009-02-05 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells to pancreatic endocrine |
| KR102026622B1 (ko) | 2008-02-21 | 2019-09-30 | 얀센 바이오테크 인코포레이티드 | 세포 부착, 배양 및 탈리를 위한 방법, 표면 개질 플레이트 및 조성물 |
| CN102159703B (zh) | 2008-06-30 | 2015-11-25 | 森托科尔奥索生物科技公司 | 多能干细胞的分化 |
| MX2011004565A (es) | 2008-10-31 | 2011-07-28 | Centocor Ortho Biotech Inc | Diferenciacion de celulas madre embrionarias humanas al linaje endocrino pancreatico. |
| RU2555538C2 (ru) | 2008-11-20 | 2015-07-10 | Сентокор Орто Байотек Инк. | Культура плюрипотентных стволовых клеток на микроносителях |
| CA2744227C (en) | 2008-11-20 | 2018-10-02 | Centocor Ortho Biotech Inc. | Methods and compositions for cell attachment and cultivation on planar substrates |
| JP6219568B2 (ja) | 2009-07-20 | 2017-10-25 | ヤンセン バイオテツク，インコーポレーテツド | ヒト胚性幹細胞の分化 |
| US9150833B2 (en) | 2009-12-23 | 2015-10-06 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| SG183535A1 (en) | 2010-03-01 | 2012-10-30 | Janssen Biotech Inc | Methods for purifying cells derived from pluripotent stem cells |
| US9719068B2 (en) | 2010-05-06 | 2017-08-01 | Children's Hospital Medical Center | Methods and systems for converting precursor cells into intestinal tissues through directed differentiation |
| PH12013500367A1 (en) | 2010-08-31 | 2013-04-01 | Janssen Biotech Inc | Differentiation of human embryonic stem cells |
| US9388386B2 (en) | 2011-12-22 | 2016-07-12 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into single hormonal insulin positive cells |
| US10653824B2 (en) | 2012-05-25 | 2020-05-19 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
| KR102667288B1 (ko) | 2012-06-08 | 2024-05-17 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 췌장 내분비 세포로의 분화 |
| USD1009775S1 (en) | 2014-10-15 | 2024-01-02 | Maxeon Solar Pte. Ltd. | Solar panel |
| USD933584S1 (en) | 2012-11-08 | 2021-10-19 | Sunpower Corporation | Solar panel |
| JP6529440B2 (ja) | 2012-12-31 | 2019-06-12 | ヤンセン バイオテツク，インコーポレーテツド | 膵内分泌細胞への分化のためのヒト多能性細胞の懸濁及びクラスタリング |
| US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
| EP2938723B1 (en) | 2012-12-31 | 2023-02-01 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators |
| RU2768963C2 (ru) | 2012-12-31 | 2022-03-25 | Янссен Байотек, Инк. | Культивация эмбриональных стволовых клеток человека в воздушно-жидкостной зоне взаимодействия с целью их дифференцировки в панкреатические эндокринные клетки |
| WO2014164621A1 (en) | 2013-03-12 | 2014-10-09 | Lockheed Martin Corporation | Method for forming filter with uniform aperture size |
| BR112015030946A8 (pt) | 2013-06-11 | 2020-01-28 | Harvard College | composição compreendendo uma célula ß pancreática não-nativa, método de diferenciação de células progenitoras em células ß pancreáticas in vitro e uso de uma célula ß pancreática não-nativa |
| US9572918B2 (en) | 2013-06-21 | 2017-02-21 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
| CN106029596A (zh) | 2014-01-31 | 2016-10-12 | 洛克希德马丁公司 | 采用多孔非牺牲性支撑层的二维材料形成复合结构的方法 |
| WO2015175307A1 (en) | 2014-05-16 | 2015-11-19 | Janssen Biotech, Inc. | Use of small molecules to enhance mafa expression in pancreatic endocrine cells |
| US10472610B2 (en) | 2014-05-21 | 2019-11-12 | Kyoto University | Method for generating pancreatic bud cells and therapeutic agent for pancreatic disease containing pancreatic bud cells |
| ES2860423T3 (es) | 2014-05-28 | 2021-10-05 | Childrens Hospital Med Ct | Métodos y sistemas para convertir células precursoras en tejidos gástricos mediante diferenciación dirigida |
| MX2017002738A (es) | 2014-09-02 | 2017-08-02 | Lockheed Corp | Membranas de hemodialisis y hemofiltracion basadas en un material de membrana bidimensional y metodos que emplean las mismas. |
| CN107075471A (zh) * | 2014-10-08 | 2017-08-18 | 新加坡科技研究局 | 将干细胞分化为肝细胞谱系的方法 |
| USD896747S1 (en) | 2014-10-15 | 2020-09-22 | Sunpower Corporation | Solar panel |
| USD999723S1 (en) | 2014-10-15 | 2023-09-26 | Sunpower Corporation | Solar panel |
| USD913210S1 (en) | 2014-10-15 | 2021-03-16 | Sunpower Corporation | Solar panel |
| USD933585S1 (en) | 2014-10-15 | 2021-10-19 | Sunpower Corporation | Solar panel |
| EP3207123A1 (en) | 2014-10-17 | 2017-08-23 | Children's Hospital Center D/b/a Cincinnati Children's Hospital Medical Center | In vivo model of human small intestine using pluripotent stem cells and methods of making and using same |
| CN113234661A (zh) | 2014-12-18 | 2021-08-10 | 哈佛学院校长同事会 | 干细胞来源的β细胞的产生方法及其使用方法 |
| WO2016100898A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof |
| ES2985135T3 (es) | 2014-12-18 | 2024-11-04 | Harvard College | Procedimientos para generar células ß derivadas de células madre y usos de las mismas |
| EP3234109A4 (en) | 2014-12-19 | 2018-06-27 | Janssen Biotech, Inc. | Suspension culturing of pluripotent stem cells |
| JPWO2016104541A1 (ja) * | 2014-12-24 | 2017-10-05 | 国立大学法人京都大学 | 内胚葉系細胞の製造方法、肝臓細胞の製造方法、膵臓細胞の製造方法、内胚葉系細胞の誘導促進剤、肝臓細胞の誘導促進キット、膵臓細胞の誘導促進キット、およびマイクロ流体デバイス |
| CN107530379A (zh) | 2015-03-11 | 2018-01-02 | 佩特尼资源有限公司 | 用于治疗肥胖症和2型糖尿病(t2d)的胰腺内分泌祖细胞疗法 |
| EP3822339A1 (en) | 2015-04-03 | 2021-05-19 | Propagenix Inc. | Ex vivo proliferation of epithelial cells |
| EP3081633A1 (en) | 2015-04-16 | 2016-10-19 | ARKRAY, Inc. | Device and system for cell culture |
| JP2016202172A (ja) | 2015-04-16 | 2016-12-08 | 国立大学法人京都大学 | 疑似膵島の製造方法 |
| PT3286300T (pt) | 2015-04-24 | 2020-12-28 | Univ Copenhagen | Isolamento de células progenitoras pancreáticas genuínas |
| CA2994549A1 (en) | 2015-08-05 | 2017-02-09 | Lockheed Martin Corporation | Perforatable sheets of graphene-based material |
| MX2018001559A (es) | 2015-08-06 | 2018-09-27 | Lockheed Corp | Modificacion de nanoparticula y perforacion de grafeno. |
| JP6869231B2 (ja) * | 2015-09-11 | 2021-05-12 | プロパジェニクス インコーポレイテッド | ｅｘ ｖｉｖｏでの上皮細胞の増殖 |
| JP6937513B2 (ja) * | 2015-09-11 | 2021-09-22 | 国立研究開発法人理化学研究所 | 転写因子結合部位特異的なｄｎａ脱メチル化方法 |
| US10370637B2 (en) | 2015-12-15 | 2019-08-06 | The Regents Of The University Of California | Technology for sustaining pluripotency and improved growth of stem cells in culture |
| KR20190018410A (ko) | 2016-04-14 | 2019-02-22 | 록히드 마틴 코포레이션 | 흐름 통로들을 갖는 2차원 막 구조들 |
| SG11201808962RA (en) | 2016-04-14 | 2018-11-29 | Lockheed Corp | Method for treating graphene sheets for large-scale transfer using free-float method |
| WO2017180135A1 (en) | 2016-04-14 | 2017-10-19 | Lockheed Martin Corporation | Membranes with tunable selectivity |
| KR20180133430A (ko) | 2016-04-14 | 2018-12-14 | 록히드 마틴 코포레이션 | 결함 형성 또는 힐링의 인 시츄 모니터링 및 제어를 위한 방법 |
| WO2017180141A1 (en) | 2016-04-14 | 2017-10-19 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
| MA45479A (fr) | 2016-04-14 | 2019-02-20 | Janssen Biotech Inc | Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen |
| JP7244418B2 (ja) | 2016-11-04 | 2023-03-22 | チルドレンズ ホスピタル メディカル センター | 肝臓オルガノイド疾患モデルおよびその作製方法 |
| USD824042S1 (en) | 2016-11-10 | 2018-07-24 | Viacyte, Inc. | Perforated cell encapsulation device |
| JP7088564B2 (ja) | 2016-11-10 | 2022-06-21 | ヴィアサイト，インコーポレイテッド | 細胞送達装置におけるｐｄｘ１膵臓内胚葉細胞及びその方法 |
| WO2018094107A1 (en) * | 2016-11-17 | 2018-05-24 | Baylor College Of Medicine | Recreation of pancreatic niche allows for novel methods for human, mature beta derivation from pluripotent stem cells |
| WO2018106628A1 (en) | 2016-12-05 | 2018-06-14 | Children's Hospital Medical Center | Colonic organoids and methods of making and using same |
| CN110392735A (zh) * | 2017-01-17 | 2019-10-29 | 新加坡科技研究局 | 胰腺祖细胞的维持和扩增 |
| KR102861022B1 (ko) * | 2017-03-21 | 2025-09-18 | 에따블리스망 프랑스와 뒤 상 | 조혈 이식체의 개선 방법 |
| US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
| EP3609997A4 (en) | 2017-04-14 | 2021-03-03 | Children's Hospital Medical Center | COMPOSITIONS OF STEM CELLS FROM MULTIPLE DONOR CELLS AND THEIR PREPARATION PROCEDURES |
| NZ800904A (en) | 2017-06-14 | 2025-08-29 | Vertex Pharma | Devices and methods for delivering therapeutics |
| US10391156B2 (en) | 2017-07-12 | 2019-08-27 | Viacyte, Inc. | University donor cells and related methods |
| EP3654996A4 (en) * | 2017-07-21 | 2021-03-24 | Semma Therapeutics, Inc. | REAGGREGATION OF PANCREATIC BETA CELLS DERIVED FROM STEM CELLS |
| JP7389020B2 (ja) * | 2017-09-11 | 2023-11-29 | ノヴォ ノルディスク アー／エス | 幹細胞からインビトロで誘導されたｎｋｘ６．１およびｃ－ペプチド共発現細胞の濃縮 |
| CA3077442A1 (en) | 2017-10-10 | 2019-04-18 | Children's Hospital Medical Center | Esophageal tissue and/or organoid compositions and methods of making same |
| CA2983845C (en) | 2017-10-26 | 2024-01-30 | University Of Copenhagen | Generation of glucose-responsive beta cells |
| EP3710021A4 (en) * | 2017-11-15 | 2021-08-11 | Semma Therapeutics, Inc. | ISLAND CELL MANUFACTURING COMPOSITIONS AND METHOD OF USE |
| US12379372B2 (en) | 2017-12-21 | 2025-08-05 | Children's Hospital Medical Center | Digitalized human organoids and methods of using same |
| ES2958118T3 (es) | 2018-01-18 | 2024-02-01 | Daiichi Sankyo Co Ltd | Derivado de dihidroindolizinona |
| CN111684060B (zh) * | 2018-01-30 | 2023-11-03 | 株式会社片冈制作所 | 产胰岛素细胞的制备方法 |
| IL316168A (en) * | 2018-03-02 | 2024-12-01 | Vertex Pharma | Methods of enhancing stem cell differentiation into beta cells |
| CN112533619A (zh) | 2018-07-26 | 2021-03-19 | 儿童医院医学中心 | 肝-胆-胰组织和其制备方法 |
| WO2020033879A1 (en) | 2018-08-10 | 2020-02-13 | Semma Therapeutics, Inc. | Stem cell derived islet differentiation |
| US10724052B2 (en) | 2018-09-07 | 2020-07-28 | Crispr Therapeutics Ag | Universal donor cells |
| SG11202102431YA (en) | 2018-09-12 | 2021-04-29 | Childrens Hospital Med Ct | Organoid compositions for the production of hematopoietic stem cells and derivatives thereof |
| EP4386081A3 (en) * | 2019-05-21 | 2024-10-16 | President and Fellows of Harvard College | Endocrine differentiation-inducing molecule |
| CN114173837A (zh) | 2019-05-31 | 2022-03-11 | W.L.戈尔及同仁股份有限公司 | 生物相容性膜复合材料 |
| WO2020243613A1 (en) | 2019-05-31 | 2020-12-03 | Children's Hospital Medical Center | Methods of generating and expanding hematopoietic stem cells |
| EP3975926A1 (en) | 2019-05-31 | 2022-04-06 | W.L. Gore & Associates, Inc. | A biocompatible membrane composite |
| CA3257300A1 (en) | 2019-05-31 | 2025-06-12 | W. L. Gore & Associates, Inc. | Cell encapsulation devices with controlled oxygen diffusion distances |
| EP3976236A1 (en) | 2019-05-31 | 2022-04-06 | W.L. Gore & Associates Inc. | A biocompatible membrane composite |
| EP4013853A4 (en) * | 2019-08-13 | 2023-08-23 | Children's Hospital Medical Center | IMPROVED METHODS FOR PRODUCTION OF ORGANOID COMPOSITIONS |
| EP4025690A1 (en) | 2019-09-05 | 2022-07-13 | CRISPR Therapeutics AG | Universal donor cells |
| US11116797B2 (en) | 2019-09-05 | 2021-09-14 | Crispr Therapeutics Ag | Universal donor cells |
| US20240158756A1 (en) * | 2019-10-10 | 2024-05-16 | University Of Houston System | Feeder-based and feeder-free stem cell culture systems for stratified epithelial stem cells, and uses related thereto |
| JP7721105B2 (ja) * | 2020-01-17 | 2025-08-12 | 国立大学法人京都大学 | 膵内胚葉細胞の増殖を促進する方法及びキット |
| US20230392124A1 (en) * | 2020-04-16 | 2023-12-07 | Washington University | Methods and compositions for improving sc-beta cells or enhancing their utility |
| CN113637630B (zh) * | 2020-05-11 | 2024-03-29 | 中国科学院分子细胞科学卓越创新中心 | 一种胰岛样细胞团及其制法和应用 |
| IL300105A (en) | 2020-07-31 | 2023-03-01 | Vertex Pharma | Pancreatic endocrine cell differentiation |
| CN116018150A (zh) * | 2020-08-28 | 2023-04-25 | 诺和诺德股份有限公司 | 用于筛选干细胞衍生的β样细胞的体外群体的方法及其新型标志物 |
| EP4271796A1 (en) | 2020-12-31 | 2023-11-08 | CRISPR Therapeutics AG | Universal donor cells |
| CN114350598A (zh) * | 2021-12-03 | 2022-04-15 | 深圳华源再生医学有限公司 | 一种多能干细胞体外形成3d球的培养方法 |
| IL316055A (en) | 2022-04-15 | 2024-11-01 | Aspen Neuroscience Inc | Methods of classifying the differentiation state of cells and related compositions of differentiated cells |
| CA3249630A1 (en) | 2022-04-21 | 2023-10-26 | Evotec International Gmbh | NEW CELL POPULATIONS AND MEANS AND METHODS FOR THEIR DIFFERENTIATION AND PRESERVATION |
| WO2024020587A2 (en) | 2022-07-22 | 2024-01-25 | Tome Biosciences, Inc. | Pleiopluripotent stem cell programmable gene insertion |
| WO2024151541A1 (en) | 2023-01-09 | 2024-07-18 | Sana Biotechnology, Inc. | Type-1 diabetes autoimmune mouse |
| WO2024243236A2 (en) | 2023-05-22 | 2024-11-28 | Sana Biotechnology, Inc. | Methods of delivery of islet cells and related methods |
| WO2025117331A1 (en) | 2023-12-01 | 2025-06-05 | Eli Lilly And Company | Methods of making stem cell-derived islet-like cells, as well as populations and compositions including the same |
Family Cites Families (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US800807A (en) | 1905-04-03 | 1905-10-03 | Hans P Larsen | Composition of matter for soldering. |
| US2161804A (en) | 1935-11-09 | 1939-06-13 | Baldwin Southwark Corp | Hydraulic press |
| US5529914A (en) | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials |
| KR0133372B1 (ko) | 1991-09-06 | 1998-04-23 | 고야 다다시 | 4-아미노(알킬)시클로헥산-1-카르복사미드 화합물 및 그 용도 |
| US5453357A (en) | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
| US5690926A (en) | 1992-10-08 | 1997-11-25 | Vanderbilt University | Pluripotential embryonic cells and methods of making same |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US20030059913A1 (en) | 1995-11-20 | 2003-03-27 | Walter Weyler | Novel Microorganisms with ability to degrade indole and novel enzymes therefrom |
| WO1997032033A1 (en) | 1996-02-28 | 1997-09-04 | Vanderbilt University | Compositions and methods of making embryonic stem cells |
| US6075007A (en) | 1997-07-17 | 2000-06-13 | Regeneron Pharmaceuticals, Inc. | Modified noggin polypeptide and compositions |
| EP1025204A4 (en) | 1997-10-23 | 2001-02-28 | Geron Corp | Methods and materials for the growth of primate-derived primordial stem cells |
| US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
| JP2003520266A (ja) | 2000-01-24 | 2003-07-02 | メルク シャープ エンド ドーム リミテッド | γ−セクレターゼ阻害薬 |
| GB0005251D0 (en) | 2000-03-03 | 2000-04-26 | Merck Sharp & Dohme | Therapeutic compounds |
| US7005252B1 (en) | 2000-03-09 | 2006-02-28 | Wisconsin Alumni Research Foundation | Serum free cultivation of primate embryonic stem cells |
| GB0008710D0 (en) | 2000-04-07 | 2000-05-31 | Merck Sharp & Dohme | Therapeutic compounds |
| CA2427206C (en) | 2000-11-02 | 2011-06-28 | Merck Sharp & Dohme Limited | Sulfamides as gamma-secretase inhibitors |
| JP2002184539A (ja) | 2000-12-14 | 2002-06-28 | Auto Network Gijutsu Kenkyusho:Kk | コネクタ |
| DE60218138T2 (de) | 2001-03-23 | 2007-09-20 | Bayer Pharmaceuticals Corp., West Haven | Rho-kinase inhibitoren |
| US20030125344A1 (en) | 2001-03-23 | 2003-07-03 | Bayer Corporation | Rho-kinase inhibitors |
| US7432104B2 (en) | 2001-08-06 | 2008-10-07 | Bresgen Inc. | Methods for the culture of human embryonic stem cells on human feeder cells |
| JP2003097552A (ja) | 2001-09-21 | 2003-04-03 | Nsk Ltd | 摩擦付加装置および直動案内装置 |
| US20030062225A1 (en) | 2001-10-03 | 2003-04-03 | Stucky Paul A. | Elevator load bearing assembly having a detectable element that is indicative of local strain |
| US20030077256A1 (en) * | 2001-10-19 | 2003-04-24 | Paul Czernichow | Pancreas regeneration using embryonic pancreatic cells |
| GB2399823B (en) | 2001-12-07 | 2006-02-15 | Geron Corp | Islet cells from primate pluripotent stem cells |
| DE10297545T5 (de) | 2001-12-13 | 2005-01-13 | General Binding Corp., Northbrook | Transportsystem für Blattübergabe zwischen Blatt- oder Blattstapel verarbeitender Ausrüstung |
| EP1465900B1 (en) | 2002-01-10 | 2008-05-14 | Bayer HealthCare AG | Rho-kinase inhibitors |
| ATE381557T1 (de) | 2002-01-23 | 2008-01-15 | Bayer Pharmaceuticals Corp | Rho-kinase inhibitoren |
| US6924290B2 (en) | 2002-01-23 | 2005-08-02 | Bayer Pharmaceuticals Corporation | Rho-kinase inhibitors |
| US20040039796A1 (en) | 2002-08-08 | 2004-02-26 | Virtual Radio, Inc. | Personalized cyber disk jockey and Internet radio advertising |
| GB0223038D0 (en) | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
| GB0223039D0 (en) | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
| KR20050055760A (ko) | 2002-10-11 | 2005-06-13 | 노보셀, 인크 | 질병 치료를 위한 캡슐화 생물학적 물질의 이식 |
| DE50304983D1 (de) | 2002-10-28 | 2006-10-19 | Bayer Healthcare Ag | Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren |
| GB0225474D0 (en) | 2002-11-01 | 2002-12-11 | Merck Sharp & Dohme | Therapeutic agents |
| GB0326039D0 (en) | 2003-11-07 | 2003-12-10 | Merck Sharp & Dohme | Therapeutic agents |
| US20050266554A1 (en) | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
| US7541185B2 (en) | 2003-12-23 | 2009-06-02 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
| MXPA06007252A (es) | 2003-12-23 | 2007-01-23 | Cythera Inc | Endodermo definitivo. |
| JP4901471B2 (ja) | 2004-02-19 | 2012-03-21 | 国立大学法人京都大学 | 体細胞核初期化物質のスクリーニング方法 |
| US8597947B2 (en) * | 2004-12-29 | 2013-12-03 | Hadasit Medical Research Services & Development Limited | Undifferentiated stem cell culture systems |
| US7739764B2 (en) | 2005-04-27 | 2010-06-22 | Whirlpool Corporation | Method and apparatus for monitoring load size and load imbalance in washing machine |
| EP3584311A1 (en) | 2005-10-27 | 2019-12-25 | Viacyte, Inc. | Pdx-1 expressing dorsal and ventral foregut endoderm |
| US8278104B2 (en) | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
| CN105802904B (zh) | 2006-02-23 | 2021-04-20 | 维亚赛特公司 | 用于培养可分化细胞的组合物和方法 |
| US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
| DK1999253T3 (da) | 2006-03-02 | 2019-08-12 | Viacyte Inc | Endokrine precursorceller, pankreatiske hormon-udtrykkende celler og fremgangsmåder til fremstilling |
| US7964402B2 (en) | 2006-05-25 | 2011-06-21 | Sanford-Burnham Medical Research Institute | Methods for culture and production of single cell populations of human embryonic stem cells |
| WO2007143193A1 (en) * | 2006-06-02 | 2007-12-13 | University Of Georgia Research Foundation, Inc. | Pancreatic and liver endoderm cells and tissue by differentiation of definitive endoderm cells obtained from human embryonic stems |
| WO2008013664A2 (en) | 2006-07-26 | 2008-01-31 | Cythera, Inc. | Methods of producing pancreatic hormones |
| DK177279B1 (da) | 2006-07-27 | 2012-09-24 | Vegano Aps | Ukrudtsmiddel samt fremgangsmåde til fremstilling |
| CN101743306A (zh) | 2007-03-23 | 2010-06-16 | 威斯康星校友研究基金会 | 体细胞重编程 |
| CA2693156C (en) * | 2007-07-18 | 2018-03-06 | Alireza Rezania | Differentiation of human embryonic stem cells |
| US7695963B2 (en) | 2007-09-24 | 2010-04-13 | Cythera, Inc. | Methods for increasing definitive endoderm production |
| US8623650B2 (en) | 2007-10-19 | 2014-01-07 | Viacyte, Inc. | Methods and compositions for feeder-free pluripotent stem cell media containing human serum |
| RU2391401C2 (ru) * | 2008-02-12 | 2010-06-10 | Общество с ограниченной ответственностью "Лаборатория клеточного мониторинга" | СПОСОБ ПОЛУЧЕНИЯ ПОПУЛЯЦИИ CD4+CD25+Foxp3+ Т-ЛИМФОЦИТОВ ЧЕЛОВЕКА ex vivo, СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ |
| CN104694570B (zh) | 2008-03-17 | 2019-07-16 | 斯克里普斯研究所 | 用于产生诱导的多能干细胞的组合化学遗传方法 |
| RU2359030C1 (ru) * | 2008-03-19 | 2009-06-20 | Общество С Ограниченной Ответственностью "Лаборатория Клеточных Технологий" | Способ получения эндотелиальных клеток из эмбриональных стволовых клеток человека (варианты) |
| US8338170B2 (en) | 2008-04-21 | 2012-12-25 | Viacyte, Inc. | Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
| DK2727998T3 (da) * | 2008-04-21 | 2019-08-26 | Viacyte Inc | Fremgangsmåder til oprensning af pancreatiske endodermceller afledt fra humane embryoniske stamceller |
| EP2993226B1 (en) | 2008-06-03 | 2020-12-16 | Viacyte, Inc. | Growth factors for production of definitive endoderm |
| US20090298178A1 (en) | 2008-06-03 | 2009-12-03 | D Amour Kevin Allen | Growth factors for production of definitive endoderm |
| WO2009149233A1 (en) | 2008-06-04 | 2009-12-10 | Stem Cell Products, Inc. | Methods for the production of ips cells using non-viral approach |
| AU2008363829B2 (en) | 2008-11-04 | 2014-11-20 | Viacyte, Inc. | Stem cell aggregate suspension compositions and methods for differentiation thereof |
| US8008075B2 (en) | 2008-11-04 | 2011-08-30 | Viacyte, Inc. | Stem cell aggregate suspension compositions and methods of differentiation thereof |
| JP2012508584A (ja) * | 2008-11-14 | 2012-04-12 | ヴィアサイト，インコーポレイテッド | ヒト多能性幹細胞由来膵臓細胞のカプセル化 |
| JP5488000B2 (ja) | 2009-02-02 | 2014-05-14 | リコーイメージング株式会社 | 高変倍ズームレンズ系 |
| DK2421957T3 (da) * | 2009-04-22 | 2021-01-25 | Viacyte Inc | Cellesammensætninger afledt af dedifferentierede omprogrammerede celler |
| US9328331B2 (en) * | 2009-05-21 | 2016-05-03 | Joslin Diabetes Center, Inc. | Compositions and methods for promoting beta cell maturity |
| ES2693088T3 (es) * | 2009-07-20 | 2018-12-07 | Janssen Biotech, Inc. | Diferenciación de células madre embriónicas humanas |
| AU2010333840B2 (en) | 2009-12-23 | 2016-01-07 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| US9150833B2 (en) | 2009-12-23 | 2015-10-06 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| US9359005B2 (en) | 2009-12-29 | 2016-06-07 | Fori Automation, Inc. | Drive mechanism for automated guided vehicle |
| US8424928B2 (en) | 2010-09-24 | 2013-04-23 | Thase Enterprise Co., Ltd. | Door handle having a handgrip changeable indoor and outdoor |
| US20120270890A1 (en) | 2011-04-22 | 2012-10-25 | Cheng-Ho Chung | Methods of Pancreatic Beta Cell Regeneration |
| US9388386B2 (en) | 2011-12-22 | 2016-07-12 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into single hormonal insulin positive cells |
| KR102667288B1 (ko) | 2012-06-08 | 2024-05-17 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 췌장 내분비 세포로의 분화 |
| MX352528B (es) | 2012-10-01 | 2017-11-29 | Nissan Motor | Dispositivo de control de estabilidad. |
| RU2768963C2 (ru) * | 2012-12-31 | 2022-03-25 | Янссен Байотек, Инк. | Культивация эмбриональных стволовых клеток человека в воздушно-жидкостной зоне взаимодействия с целью их дифференцировки в панкреатические эндокринные клетки |
| DE102013212018A1 (de) | 2013-06-25 | 2015-01-08 | Evonik Industries Ag | Metalloxid-Prekursoren, sie enthaltende Beschichtungszusammensetzungen, und ihre Verwendung |
| US10702008B2 (en) | 2018-02-26 | 2020-07-07 | Hbn Shoe, Llc | Device and method of constructing shoes |
| EP3986392A4 (en) | 2019-06-20 | 2023-07-12 | ChemoCentryx, Inc. | COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES |
| US12108408B2 (en) | 2020-10-01 | 2024-10-01 | Qualcomm Incorporated | Providing cross-carrier scheduling control information for a primary cell via both a secondary cell and the primary cell |
| US11586805B2 (en) | 2021-07-26 | 2023-02-21 | Atlassian Pty Ltd. | Machine-learning-based natural language processing techniques for low-latency document summarization |
| US12463142B1 (en) | 2021-10-01 | 2025-11-04 | Kepler Computing Inc. | Integrating embedded memory with logic interconnects |
-
2013
- 2013-12-13 US US14/106,330 patent/US8859286B2/en active Active
-
2014
- 2014-03-13 DK DK14721621.2T patent/DK2970899T3/da active
- 2014-03-13 KR KR1020157023869A patent/KR102077367B1/ko active Active
- 2014-03-13 CA CA2897984A patent/CA2897984C/en active Active
- 2014-03-13 AU AU2014243791A patent/AU2014243791B2/en active Active
- 2014-03-13 SG SG11201505866RA patent/SG11201505866RA/en unknown
- 2014-03-13 CA CA3204013A patent/CA3204013A1/en active Pending
- 2014-03-13 KR KR1020217024674A patent/KR102328311B1/ko active Active
- 2014-03-13 WO PCT/US2014/026529 patent/WO2014160413A1/en not_active Ceased
- 2014-03-13 KR KR1020247027970A patent/KR20240134215A/ko active Pending
- 2014-03-13 KR KR1020217037206A patent/KR102698731B1/ko active Active
- 2014-03-13 IL IL317491A patent/IL317491A/en unknown
- 2014-03-13 IL IL294691A patent/IL294691B2/en unknown
- 2014-03-13 JP JP2016502165A patent/JP6219494B2/ja active Active
- 2014-03-13 KR KR1020217008074A patent/KR102288191B1/ko active Active
- 2014-03-13 RU RU2015137400A patent/RU2670064C2/ru active
- 2014-03-13 EP EP19165436.7A patent/EP3521418A1/en active Pending
- 2014-03-13 ES ES14721621T patent/ES2739082T3/es active Active
- 2014-03-13 EP EP14721621.2A patent/EP2970899B1/en active Active
- 2014-03-13 RU RU2018134644A patent/RU2734657C2/ru active
- 2014-03-13 KR KR1020207003538A patent/KR102187510B1/ko active Active
- 2014-03-13 KR KR1020207034523A patent/KR102231393B1/ko active Active
- 2014-03-13 SG SG10201610787XA patent/SG10201610787XA/en unknown
- 2014-08-08 US US14/455,059 patent/US9650610B2/en active Active
-
2015
- 2015-07-20 IL IL240028A patent/IL240028B/en active IP Right Grant
-
2017
- 2017-04-03 US US15/478,094 patent/US10376545B2/en active Active
- 2017-07-10 JP JP2017134591A patent/JP6355802B2/ja active Active
-
2018
- 2018-06-12 JP JP2018111865A patent/JP6654664B2/ja active Active
-
2019
- 2019-04-23 AU AU2019202849A patent/AU2019202849B2/en active Active
- 2019-06-25 US US16/452,415 patent/US11446335B2/en active Active
- 2019-11-15 AU AU2019264658A patent/AU2019264658B2/en active Active
-
2020
- 2020-01-30 JP JP2020013240A patent/JP6966583B2/ja active Active
- 2020-10-05 RU RU2020132715A patent/RU2764465C1/ru active
-
2021
- 2021-05-10 AU AU2021202943A patent/AU2021202943C1/en active Active
- 2021-05-10 IL IL283094A patent/IL283094A/en unknown
- 2021-10-21 JP JP2021172066A patent/JP7187647B2/ja active Active
- 2021-11-12 AU AU2021266324A patent/AU2021266324C1/en active Active
-
2022
- 2022-08-24 US US17/894,816 patent/US20230165908A1/en active Pending
- 2022-11-30 JP JP2022191126A patent/JP7490035B2/ja active Active
-
2023
- 2023-03-15 AU AU2023201602A patent/AU2023201602B2/en active Active
-
2024
- 2024-05-13 US US18/662,902 patent/US20240299462A1/en not_active Abandoned
- 2024-05-14 JP JP2024078496A patent/JP2024112871A/ja active Pending